Stay updated with breaking news from Cutaneoust Cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
THE HAGUE, Netherlands, Oct. 14, 2021 /PRNewswire/ -- Dutch biotechnology company Micreos has recruited Matt Regan as CEO of its new Pharmaceutical business that will be based in Switzerland.
Press release content from PR Newswire. The AP news staff was not involved in its creation.
NICE uphold appeal by Kyowa Kirin, for POTELIGEO in the treatment of those living with certain ultra-rare blood cancers The National Institute for Health and Care Excellence (NICE) has upheld an appeal
For Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma Tokyo, May 19, 2021 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has launched the anticancer agent "Remitoro® for Intravenous Drip Infusion 300µg" (Denileukin Diftitox (Genetical Recombination)) with the indications of relapsed or refractory Peripheral T-cell Lymphoma (PTCL) and relapsed or refractory Cutaneous T-cell Lymphoma (CTCL), in Japan. Eisai obtained the manufacturing and marketing approval of Remitoro on March 23, 2021. Remitoro was included to Japan's National Health Insurance Drug Price List on May 19, 20...
Shares of Brickell Biotech (NASDAQ:BBI) moved higher in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share ...